Pharmacometabonomics and personalized medicine
The DOI matches its Crossref record; 112 of the 113 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Pharmacometabonomics is a new branch of science, first described in 2006 and defined as 'the prediction of the effects of a drug on the basis of a mathematical model of pre-dose metabolite profiles'. Pharmacometabonomics has been used to predict drug metabolism, pharmacokinetics (PK), drug safety and drug efficacy in both animals and humans and is complementary to both pharmacogenomics (PGx) and pharmacoproteomics. METHODS: A literature review using the search terms pharmacometabonomics, pharmacometabolomics, pharmaco-metabonomics, pharmaco-metabolomics and the singular form of all those terms was conducted in October 2012 using PubMed and Web of Science. The review was updated until mid April 2013. RESULTS: Since the original description of pharmacometabonomics in 2006, 21 original publications and eight reviews have emerged, covering a broad range of applications from the prediction of PK to the prediction of drug metabolism, efficacy and safety in humans and animals. CONCLUSIONS: Pharmacometabonomics promises to be an important new approach to the delivery of personalized medicine to improve both drug efficacy and safety for patients in the future. Pharmacometabonomics is particularly powerful as it is sensitive to both genetic and environmental factors such as diet, drug intake and most importantly, a person's microbiome. PGx is now over 50 years old and although it has not achieved as much as some hoped, it is starting to have important applications in personalized medicine. We predict that pharmacometabonomics will be equally important in the next few decades and will be both valuable in its own right and complementary to pharmacoproteomics and PGx.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, drug toxicities and efficacies greatly vary depending on the individual patient, given both genetic81 and environmental influences (eg, nutrients,82, 83 drug intake,83, 84 gut microbiome85, 86).”
From Microfluidic Organ-on-a-Chip Models of Human Intestine (2018) · cites this paper as [83]
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Metabolomics—the link between genotypes and phenotypes
Fiehn, O. (2002) · Plant Molecular Biology · doi:10.1023/a:1013713905833 · Cited by 3,445
Metabolomics — the link between genotypes and phenotypes
Fiehn, O. (2002) · Functional Genomics · doi:10.1007/978-94-010-0448-0_11 · Cited by 3,167
A framework for human microbiome research
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11209 · Cited by 2,650
Orthogonal projections to latent structures (O‐PLS)
Trygg, J., & Wold, S. (2002) · Journal of Chemometrics · doi:10.1002/cem.695 · Cited by 2,447
Metabolite profiling for plant functional genomics
Fiehn, O., Kopka, J., Dörmann, P., Altmann, T., Trethewey, R. N., & Willmitzer, L. (2000) · Nature Biotechnology · doi:10.1038/81137 · Cited by 2,127
Systematic functional analysis of the yeast genome
Oliver, S. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(98)01214-1 · Cited by 1,302
Global metabolic profiling procedures for urine using UPLC–MS
Want, E. J., Wilson, I. D., Gika, H., Theodoridis, G., Plumb, R. S., Shockcor, J., Holmes, E., & Nicholson, J. K. (2010) · Nature Protocols · doi:10.1038/nprot.2010.50 · Cited by 1,169
Symbiotic gut microbes modulate human metabolic phenotypes
Li, M., Wang, B., Zhang, M., Rantalainen, M., Wang, S., Zhou, H., Zhang, Y., Shen, J., Pang, X., Zhang, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712038105 · Cited by 1,144
Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism
Nicholson, J. K., & Wilson, I. D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1157 · Cited by 1,116
High-Resolution NMR Techniques in Organic Chemistry
(2016) · Elsevier eBooks · doi:10.1016/c2015-0-04654-8 · Cited by 946
Understanding NMR spectroscopy
(2006) · Choice Reviews Online · doi:10.5860/choice.43-5896 · Cited by 926
Genomic variation landscape of the human gut microbiome
Schloissnig, S., Arumugam, M., Sunagawa, S., Mitreva, M., Tap, J., Zhu, A., Waller, A., Mende, D. R., Kultima, J. R., Martin, J., et al. (2013) · Nature · doi:10.1038/nature11711 · Cited by 907
Pharmaco-metabonomic phenotyping and personalized drug treatment
Andrew Clayton, T., Lindon, J. C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J.-P., Le Net, J.-L., Baker, D., Walley, R. J., et al. (2006) · Nature · doi:10.1038/nature04648 · Cited by 824 · cited 10×
“002).(11) From the loadings plot (Figure 6(d)), the most Figure 4.”
BackgroundMethodInfluentialSelf-citationClayton, T. A., Baker, D., Lindon, J. C., Everett, J. R., & Nicholson, J. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904489106 · Cited by 765
Self-citationPotential Role of Pharmacogenomics in Reducing Adverse Drug Reactions: A Systematic Review
Phillips, K. A., Veenstra, D. L., Oren, E., Lee, J. K., & Sadee, W. (2001) · JAMA · doi:10.1001/jama.286.18.2270 · Cited by 705
Human Sulfotransferases and Their Role in Chemical Metabolism
Gamage, N., Barnett, A., Hempel, N., Duggleby, R. G., Windmill, K. F., Martin, J. L., & McManus, M. E. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj061 · Cited by 703
Novel biomarkers for pre-diabetes identified by metabolomics
Wang‐Sattler, R., Yu, Z., Herder, C., Messias, A. C., Floegel, A., He, Y., Heim, K., Campillos, M., Holzapfel, C., Thorand, B., et al. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.43 · Cited by 701
Gut microbiome-host interactions in health and disease
Kinross, J. M., Darzi, A. W., & Nicholson, J. K. (2011) · Genome Medicine · doi:10.1186/gm228 · Cited by 691
Metabolomics: A Global Biochemical Approach to Drug Response and Disease
Kaddurah-Daouk, R., Kristal, B. S., & Weinshilboum, R. M. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094715 · Cited by 670
Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS
Halket, J. M., Waterman, D., Przyborowska, A. M., Patel, R. K. P., Fraser, P. D., & Bramley, P. M. (2005) · Journal of Experimental Botany · doi:10.1093/jxb/eri069 · Cited by 662
Watkins, P. B., Kaplowitz, N., Slattery, J. T., Colonese, C. R., Colucci, S. V., Stewart, P. W., & Harris, S. C. (2006) · JAMA · doi:10.1001/jama.296.1.87 · Cited by 632
Ambient desorption ionization mass spectrometry
Venter, A., Nefliu, M., & Graham Cooks, R. (2008) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2008.01.010 · Cited by 552
Metabolic phenotyping in clinical and surgical environments
Nicholson, J. K., Holmes, E., Kinross, J. M., Darzi, A. W., Takats, Z., & Lindon, J. C. (2012) · Nature · doi:10.1038/nature11708 · Cited by 546
Understanding the role of gut microbiome–host metabolic signal disruption in health and disease
Holmes, E., Li, J. V., Athanasiou, T., Ashrafian, H., & Nicholson, J. K. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.05.006 · Cited by 541
Liquid chromatography–mass spectrometry based global metabolite profiling: A review
Theodoridis, G. A., Gika, H. G., Want, E. J., & Wilson, I. D. (2012) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.09.042 · Cited by 518
XPB, a subunit of TFIIH, is a target of the natural product triptolide
Titov, D. V., Gilman, B., He, Q.-L., Bhat, S., Low, W.-K., Dang, Y., Smeaton, M., Demain, A. L., Miller, P. S., Kugel, J. F., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.522 · Cited by 509
Advances in structure elucidation of small molecules using mass spectrometry
Kind, T., & Fiehn, O. (2010) · Bioanalytical Reviews · doi:10.1007/s12566-010-0015-9 · Cited by 480
Metabonomics: Metabolic processes studied by NMR spectroscopy of biofluids
Lindon, J. C., Nicholson, J. K., Holmes, E., & Everett, J. R. (2000) · Concepts in Magnetic Resonance · doi:10.1002/1099-0534(2000)12:5<289::aid-cmr3>3.0.co;2-w · Cited by 460
Leucht, S., Hierl, S., Kissling, W., Dold, M., & Davis, J. M. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.096594 · Cited by 451 · cited 1×
“The development of personalized healthcare is a necessary path for medicine to take, as it is increasingly clear that for many medicines, efficacy is only achieved in a subset of the patient population.(86) Equally, many otherwise efficacious medicines are withdrawn from the market because of safety concerns in a smal…”
BackgroundPharmacogenomics: The Inherited Basis for Interindividual Differences in Drug Response
Evans, W. E., & Johnson, J. A. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.9 · Cited by 415
(2004) · Choice Reviews Online · doi:10.5860/choice.42-0950 · Cited by 391
Global systems biology, personalized medicine and molecular epidemiology
Nicholson, J. K. (2006) · Molecular Systems Biology · doi:10.1038/msb4100095 · Cited by 388
The Handbook of Metabonomics and Metabolomics
(2007) · Elsevier eBooks · doi:10.1016/b978-0-444-52841-4.x5000-0 · Cited by 370
The importance of 3‘‐phosphoadenosine 5‘‐phosphosulfate (PAPS) in the regulation of sulfation
Klaassen, C. D., & Boles, J. W. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194521 · Cited by 357
Impact of intestinal microbiota on intestinal luminal metabolome
Matsumoto, M., Kibe, R., Ooga, T., Aiba, Y., Kurihara, S., Sawaki, E., Koga, Y., & Benno, Y. (2012) · Scientific Reports · doi:10.1038/srep00233 · Cited by 334 · cited 1×
“GABA is synthesized from glutamate in the gut microbiome by colonic bacterial decarboxylase.(55) It was concluded that gut microbiome differences between the non-responders and induced-responders accounted for the GABA faecal extract differentiation.”
BackgroundPharmacogenomics: Unlocking the Human Genome for Better Drug Therapy
McLeod, H. L., & Evans, W. E. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.101 · Cited by 331
The Footprints of Gut Microbial–Mammalian Co-Metabolism
Zheng, X., Xie, G., Zhao, A., Zhao, L., Yao, C., Chiu, N. H. L., Zhou, Z., Bao, Y., Jia, W., Nicholson, J. K., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr2007945 · Cited by 319
Gross, J. H. (2004) · Springer eBooks · doi:10.1007/3-540-36756-x · Cited by 304
Gas chromatography/mass spectrometry in metabolic profiling of biological fluids
Pasikanti, K. K., Ho, P. C., & Chan, E. C. Y. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.04.033 · Cited by 302
Schepers, E., Meert, N., Glorieux, G., Goeman, J., Van der Eycken, J., & Vanholder, R. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl584 · Cited by 296
Spectroscopic and Statistical Techniques for Information Recovery in Metabonomics and Metabolomics
Lindon, J. C., & Nicholson, J. K. (2008) · Annual Review of Analytical Chemistry · doi:10.1146/annurev.anchem.1.031207.113026 · Cited by 294
High-Resolution NMR Techniques in Organic Chemistry
(2009) · Tetrahedron Organic Chemistry Series · doi:10.1016/s1460-1567(08)x0001-7 · Cited by 274
The in vivo and in vitro protective properties of taurine
Timbrell, J. A., Seabra, V., & Waterfield, C. J. (1995) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(94)00203-y · Cited by 272
Metabolomic Mapping of Atypical Antipsychotic Effects in Schizophrenia
Kaddurah-Daouk, R., McEvoy, J., Baillie, R. A., Lee, D., Yao, J. K., Doraiswamy, P. M., & Krishnan, K. R. R. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002000 · Cited by 262
Clinical chemistry of serotonin and metabolites
Kema, I. P., de Vries, E. G. E., & Muskiet, F. A. J. (2000) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)00341-8 · Cited by 246
Formation of Phenolic and Indolic Compounds by Anaerobic Bacteria in the Human Large Intestine
Smith, E. A., & Macfarlane, G. T. (1997) · Microbial Ecology · doi:10.1007/s002489900020 · Cited by 244
Roux, A., Lison, D., Junot, C., & Heilier, J.-F. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.08.016 · Cited by 234
Theodoridis, G., Gika, H. G., & Wilson, I. D. (2011) · Mass Spectrometry Reviews · doi:10.1002/mas.20306 · Cited by 218
Jellum, E. (1977) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)81792-2 · Cited by 211
Translating Pharmacogenomics: Challenges on the Road to the Clinic
Swen, J. J., Huizinga, T. W., Gelderblom, H., de Vries, E. G. E., Assendelft, W. J. J., Kirchheiner, J., & Guchelaar, H.-J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040209 · Cited by 209
Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
Kaddurah-Daouk, R., Baillie, R. A., Zhu, H., Zeng, Z.-B., Wiest, M. M., Nguyen, U. T., Wojnoonski, K., Watkins, S. M., Trupp, M., & Krauss, R. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025482 · Cited by 193 · cited 2×
“A third publication(75) used GC-TOF MS-based metabonomic and pharmacometabonomic analysis of extracted and derivatised plasma samples from the same patients reported previously.(73,74) Lower predose concentrations of xanthine, 2-hydroxyvaleric acid, succinic acid and stearic acid and higher predose concentrations of g…”
MethodHuman Metabolic Profiles Obtained by GC and GC/MS
Horning, E. C., & Horning, M. G. (1971) · Journal of Chromatographic Science · doi:10.1093/chromsci/9.3.129 · Cited by 174
Human Metabolic Phenotypes Link Directly to Specific Dietary Preferences in Healthy Individuals
Rezzi, S., Ramadan, Z., Martin, F.-P. J., Fay, L. B., van Bladeren, P., Lindon, J. C., Nicholson, J. K., & Kochhar, S. (2007) · Journal of Proteome Research · doi:10.1021/pr070431h · Cited by 162
Ji, Y., Hebbring, S., Zhu, H., Jenkins, G. D., Biernacka, J., Snyder, K., Drews, M., Fiehn, O., Zeng, Z., Schaid, D., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.250 · Cited by 160
Use of Pharmaco-Metabonomics for Early Prediction of Acetaminophen-Induced Hepatotoxicity in Humans
Winnike, J. H., Li, Z., Wright, F. A., Macdonald, J. M., O'Connell, T. M., & Watkins, P. B. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.240 · Cited by 156
Quantitative metabolic profiling based on gas chromatography.
Gates, S. C., & Sweeley, C. C. (1978) · Clinical Chemistry · doi:10.1093/clinchem/24.10.1663 · Cited by 139
The human gut microbiome: Implications for future health care
Kinross, J. M., von Roon, A. C., Holmes, E., Darzi, A., & Nicholson, J. K. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0075-y · Cited by 137
Pharmacometabonomics as an Effector for Personalized Medicine
Nicholson, J. K., Wilson, I. D., & Lindon, J. C. (2011) · Pharmacogenomics · doi:10.2217/pgs.10.157 · Cited by 137
Kaddurah-Daouk, R., Boyle, S. H., Matson, W., Sharma, S., Matson, S., Zhu, H., Bogdanov, M. B., Churchill, E., Krishnan, R. R., Rush, A. J., et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.22 · Cited by 129
Role of taurine in preventing acetaminophen-induced hepatic injury in the rat
Waters, E., Wang, J. H., Redmond, H. P., Wu, Q. D., Kay, E. W., & Bouchier‐Hayes, D. M. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.6.g1274 · Cited by 127
Holmes, E., Loo, R. L., Cloarec, O., Coen, M., Tang, H., Maibaum, E., Bruce, S., Chan, Q., Elliott, P., Stamler, J., et al. (2007) · Analytical Chemistry · doi:10.1021/ac062305n · Cited by 124
Cost Effectiveness of Pharmacogenomics: A Critical and Systematic Review
Wong, W. B., Carlson, J. J., Thariani, R., & Veenstra, D. L. (2010) · PharmacoEconomics · doi:10.2165/11537410-000000000-00000 · Cited by 118
Cavill, R., Kamburov, A., Ellis, J. K., Athersuch, T. J., Blagrove, M. S. C., Herwig, R., Ebbels, T. M. D., & Keun, H. C. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001113 · Cited by 116
Backshall, A., Sharma, R., Clarke, S. J., & Keun, H. C. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2474 · Cited by 112
The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains
Dawson, L. F., Donahue, E. H., Cartman, S. T., Barton, R. H., Bundy, J., McNerney, R., Minton, N. P., & Wren, B. W. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-86 · Cited by 110
Kaddurah-Daouk, R., Baillie, R. A., Zhu, H., Zeng, Z.-B., Wiest, M. M., Nguyen, U. T., Watkins, S. M., & Krauss, R. M. (2010) · Metabolomics · doi:10.1007/s11306-010-0207-x · Cited by 107
Schäfer, K., Szaniszló, T., Günther, S., Balog, J., Dénes, J., Keserű, M., Dezsö, B., Tóth, M., Spengler, B., & Takáts, Z. (2011) · Analytical Chemistry · doi:10.1021/ac102613m · Cited by 100
Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment
Trupp, M., Zhu, H., Wikoff, W. R., Baillie, R. A., Zeng, Z.-B., Karp, P. D., Fiehn, O., Krauss, R. M., & Kaddurah-Daouk, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038386 · Cited by 99
Condray, R., Dougherty, G. G., Keshavan, M. S., Reddy, R. D., Haas, G. L., Montrose, D. M., Matson, W. R., McEvoy, J., Kaddurah-Daouk, R., & Yao, J. K. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001689 · Cited by 98
Role of Pharmacoproteomics in the Development of Personalized Medicine
Jain, K. (2004) · Pharmacogenomics · doi:10.1517/phgs.5.3.331.29830 · Cited by 93
Metabolomics, Metabonomics and Metabolite Profiling
(2007) · Royal Society of Chemistry eBooks · doi:10.1039/9781847558107 · Cited by 90
Metabolic phenotyping for monitoring surgical patients
Kinross, J. K., Holmes, E. C., Darzi, A. W., & Nicholson, J. K. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60171-2 · Cited by 89
Drugs, bugs, and personalized medicine: Pharmacometabonomics enters the ring
Wilson, I. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907721106 · Cited by 88
Pharmacometabonomic Phenotyping Reveals Different Responses to Xenobiotic Intervention in Rats
Li, H., Ni, Y., Su, M., Qiu, Y., Zhou, M., Qiu, M., Zhao, A., Zhao, L., & Jia, W. (2007) · Journal of Proteome Research · doi:10.1021/pr060513q · Cited by 85
Phapale, P. B., Kim, S., Lee, H. W., Lim, M., Kale, D. D., Yl, K., Cho, J., Hwang, D., & Yoon, Y.-D. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.296 · Cited by 84
Corona, G., Rizzolio, F., Giordano, A., & Toffoli, G. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24003 · Cited by 80
Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy
Keun, H. C., Sidhu, J. K., Pchejetski, D., Lewis, J. S., Marconell, H., Patterson, M., Bloom, S., Amber, V., Coombes, R. C., & Stebbing, J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1452 · Cited by 75
Pharmacometabolomics Reveals Racial Differences in Response to Atenolol Treatment
Wikoff, W. R., Frye, R. F., Zhu, H., Gong, Y., Boyle, S., Churchill, E., Cooper-Dehoff, R. M., Beitelshees, A. L., Chapman, A. B., Fiehn, O., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057639 · Cited by 72
Zhao, L., Nicholson, J. K., Lü, A., Wang, Z., Tang, H., Holmes, E. C., Shen, J., Zhang, X., Li, J. V., & Lindon, J. C. (2012) · Journal of Proteome Research · doi:10.1021/pr3001628 · Cited by 67
Pharmacogenomics: a systems approach
Wang, L. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.42 · Cited by 65
Metabonomics in Toxicity Assessment
(2005) · CRC Press eBooks · doi:10.1201/b14117 · Cited by 64
Nicholson, J. K., Everett, J. R., & Lindon, J. C. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.646987 · Cited by 60
Abo, R., Hebbring, S., Ji, Y., Zhu, H., Zeng, Z.-B., Batzler, A., Jenkins, G. D., Biernacka, J., Snyder, K., Drews, M., et al. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32835001c9 · Cited by 56
Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach
Kwon, H. N., Kim, M. K., Wen, H., Kang, S., Yang, H.-J., Choi, M.-J., Lee, H. S., Choi, D., Park, I. S., Suh, Y. J., et al. (2010) · Kidney International · doi:10.1038/ki.2010.440 · Cited by 54
Systematic Review of Pharmacoeconomic Studies of Pharmacogenomic Tests
Beaulieu, M., de Denus, S., & Lachaîne, J. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.145 · Cited by 47
Personalised medicine: not just in our genes
Kitsios, G. D., & Kent, D. M. (2012) · BMJ · doi:10.1136/bmj.e2161 · Cited by 45
Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics.
Nebert, D., & Vesell, E. (2006) · TIPS - Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.09.008 · Cited by 45
Cunningham, K., Claus, S. P., Lindon, J. C., Holmes, E. C., Everett, J. R., Nicholson, J. K., & Coen, M. (2012) · Journal of Proteome Research · doi:10.1021/pr300430u · Cited by 44
Spin-echo 1H n.m.r. spectroscopy: a new method for studying penicillin metabolism
Everett, J. R., Jennings, K. R., Woodnutt, G., & Buckingham, M. J. (1984) · Journal of the Chemical Society Chemical Communications · doi:10.1039/c39840000894 · Cited by 42
Garrison, L. P., Carlson, R. J., Carlson, J. J., Kuszler, P. C., Meckley, L. M., & Veenstra, D. L. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530801952500 · Cited by 42
Beckett, A. H., Dyk, J. M. V., Chissick, H., & Gorrod, J. W. (1971) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1971.tb08614.x · Cited by 40
Implementation of Molecular Phenotyping Approaches in the Personalized Surgical Patient Journey
Mirnezami, R., Kinross, J. K., Vorkas, P. A., Goldin, R. D., Holmes, E. C., Nicholson, J. K., & Darzi, A. W. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31823e3c43 · Cited by 39
Coen, M., Goldfain-Blanc, F., Rolland-Valognes, G., Walther, B., Robertson, D. G., Holmes, E. C., Lindon, J. C., & Nicholson, J. K. (2012) · Journal of Proteome Research · doi:10.1021/pr201161f · Cited by 39
Different Mechanism of Saturation of Acetaminophen Sulfate Conjugation in Mice and Rats
Liu, L., & Klaassen, C. D. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0151 · Cited by 38
Pharma-metabolomics in Neonatology: is it a Dream or a Fact?
Fanos, V., Barberini, L., Antonucci, R., & Atzori, L. (2012) · Current Pharmaceutical Design · doi:10.2174/1381612811209022996 · Cited by 37
The Gut Microbiota as a Target for Improved Surgical Outcome and Improved Patient Care
Kinross, J. K., von Roon, A. C., Penney, N. C., Holmes, E. C., Silk, D. B. A., Nicholson, J. K., & Darzi, A. W. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168119 · Cited by 35
Metabolomics as a tool for Personalizing Medicine: 2012 Update
Sun, J., Beger, R. D., & Schnackenberg, L. K. (2013) · Personalized Medicine · doi:10.2217/pme.13.8 · Cited by 30
Pharmacoproteomics: a chess game on a protein field
D’Alessandro, A., & Zolla, L. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.10.002 · Cited by 29
Howes, L. G., & Kostner, K. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.10.1509 · Cited by 28
Waterfield, C. J., Turton, J. A., Scales, M. D. C., & Timbrell, J. A. (1993) · Toxicology · doi:10.1016/0300-483x(93)90132-c · Cited by 27
Liu, L., Cao, B., Aa, J., Zheng, T., Shi, J., Li, M., Wang, X., Zhao, C., Xiao, W., Yu, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043389 · Cited by 20
Pharmacometabonomics, pharmacogenomics and personalized medicine.
Guţiu, I., Andrieş, A., Mircioiu, C., Rădulescu, F., Georgescu, A.-M., & Cioacă, D. (2010) · PubMed · Cited by 15
The Human Gut Microbiome: The Ghost in the Machine
Feeney, A., & Sleator, R. D. (2012) · Future Microbiology · doi:10.2217/fmb.12.105 · Cited by 14
Personal Genomics and Personalized Medicine
Bolouri, H. (2009) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/p716 · Cited by 13
Characterization of surgical aerosols by the compact single-particle mass spectrometer LAMPAS 3
Hinz, K. ‐., Gelhausen, E., Schäfer, K.-C., Takáts, Z., & Spengler, B. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5465-6 · Cited by 10
Methodological quality in pharmacogenetic studies with binary assessment of treatment response
Cobos, A., Sánchez, P., Aguado, J., & Carrasco, J. L. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834300fb · Cited by 9
Andreev, V. P. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.101 · Cited by 7
LC-MS Metabonomics Methodology in Biomarker Discovery
Lu, X., & Xu, G. (2008) · Methods in pharmacology and toxicology · doi:10.1007/978-1-59745-463-6_14 · Cited by 6
Everett, J. R., & Readshaw, S. A. (1989) · Annual Reports Section B (Organic Chemistry) · doi:10.1039/oc9898600003 · Cited by 1
Research works printed but not linked: 6
- Everett JR, 1989, Ann Rep B Royal Soc Chem Phys Methods Tech Part I, 86, Chapter 2, 3
- Everett JR, 1991, Anal Proc, 28, 181
- Everett JR, 1992, Bioanalytical approaches for drugs, including anti-asthmatics and metabolities, 3
- Knapp JS, 2010, Metabolomics : metabolites, metabonomics, and analytical technologies
- 10.1146/annurev.anchem.1.031207.113026 · DOI · Paper page
- Gutiu IA, 2010, Rom J Intern Med, 48, 187
Cited by
The growing role of precision and personalized medicine for cancer treatment
Krzyszczyk, P., Acevedo, A., Davidoff, E. J., Timmins, L. M., Marrero-Berrios, I., Patel, M., White, C., Lowe, C., Sherba, J. J., Hartmanshenn, C., et al. (2018) · TECHNOLOGY · doi:10.1142/s2339547818300020 · Cited by 698
Microfluidic Organ-on-a-Chip Models of Human Intestine
Bein, A., Shin, W., Jalili-Firoozinezhad, S., Park, M. H., Sontheimer-Phelps, A., Tovaglieri, A., Chalkiadaki, A., Kim, H. J., & Ingber, D. E. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.12.010 · Cited by 625
Metabolomics enables precision medicine: “A White Paper, Community Perspective”
for “Precision Medicine and Pharmacometabolomics Task Group”-Metabolomics Society Initiative, Beger, R. D., Dunn, W., Schmidt, M. A., Gross, S. S., Kirwan, J. A., Cascante, M., Brennan, L., Wishart, D. S., Oresic, M., et al. (2016) · Metabolomics · doi:10.1007/s11306-016-1094-6 · Cited by 592
“…of cancer chemotherapies (Backshall et al. 2011; Miolo et al. 2016; Stebbing et al. 2012) and others under pharmacometabonomics (for review see Everett et al. 2013; Everett 2015; Huang et al. 2015) all provide support for importance of inclusion of metabolomics data in precision medicine…”
BackgroundA guide to the identification of metabolites in NMR-based metabonomics/metabolomics experiments
Dona, A. C., Kyriakides, M., Scott, F., Shephard, E. A., Varshavi, D., Veselkov, K., & Everett, J. R. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.02.005 · Cited by 327
Drug-microbiota interactions: an emerging priority for precision medicine
Zhao, Q., Chen, Y., Huang, W., Zhou, H., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01619-w · Cited by 268
Metadata
- Authors
- Everett, J. R., Loo, R. L., & Pullen, F. S.
- Affiliations
- University of Greenwich (GB)
- Medway School of Pharmacy (GB)
- Venue
- Annals of Clinical Biochemistry International Journal of Laboratory Medicine
- Publisher
- SAGE Publications
- Published
- 2013-07-25
- Volume
- 50
- Issue
- 6
- Pages
- 523-545
- ISSN
- 0004-5632 (ISSN-L)
- 1758-1001
- OpenAlex
- W2141662174
- Cited by
- 75
- References
- 113
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 7 · 2020: 6 · 2019: 8 · 2018: 9 · 2017: 8 · 2016: 12 · 2015: 8 · 2014: 6 · 2013: 1
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Annals of Clinical Biochemistry International Journal of Laboratory Medicine (publishedVersion)
- PubMed (publishedVersion)
- Greenwich Academic Literature Archive (University of Greenwich) (acceptedVersion)
- Murdoch University Research Portal (submittedVersion)
- Kent Academic Repository (University of Kent) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
- Keywords
- personalized medicine, drug metabolism prediction, pharmacokinetic prediction, drug safety prediction, drug efficacy prediction, pharmacogenomics, pharmacoproteomics, gut microbiota, mathematical modeling
- MeSH terms
- Animals, Humans, Magnetic Resonance Spectroscopy, Pharmacology, Mass Spectrometry, Metabolomics, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.